Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects
The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Blockade of brain mu-opioid receptor (mu-OR) and delta-opioid receptor (delta-OR) was investigated in recently abstinent alcohol-dependent subjects (N=21) maintained on naltrexone. Subjects completed a 19-day inpatient protocol, which included alcohol abstinence followed by naltrexone treatment (50 mg) on days 15-19. Blood samples were collected after the first administration of naltrexone to evaluate serum levels of naltrexone and 6-beta-naltrexol. Regional brain mu-OR binding potential (BP) and delta-OR Ki was measured using [11C]carfentanil (CAR) positron emission tomography (PET) and [11C]methyl naltrindole ([11C]MeNTI) PET, respectively, before (day 5) and during naltrexone treatment (day 18). Naltrexone inhibition of [11C]CAR BP was near maximal across all brain regions of interest with little variability across subjects (mean+SD% inhibition=94.9+4.9%). Naltrexone only partially inhibited the [11C]MeNTI Ki and there was more variability across subjects (mean+SD% inhibition=21.1+14.49%). Peak serum levels of naltrexone were positively correlated with % inhibition of delta-OR Ki in neocortex and basal ganglia. Peak serum levels of naltrexone were not correlated with % inhibition of mu-OR BP. Peak levels of 6-beta-naltrexol were not significantly correlated with % inhibition of mu-OR BP or delta-OR Ki. Thus, the FDA recommended therapeutic dose of naltrexone was sufficient to produce near complete inhibition of the mu-OR in recently abstinent alcohol dependent subjects. The lower percent inhibition of delta-OR and greater variability in delta-OR blockade by naltrexone across subjects may contribute to individual differences in treatment outcomes to naltrexone. Further investigations on the relationship between individual differences in delta-OR blockade by naltrexone and clinical outcomes should be explored.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“following steady-state oral administration, naltrexone achieves approximately 95% mu opioid receptor occupancy”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [122]
Citations
Cites
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988 · cited 1×
“Subjects completed the Clinical Institute Withdrawal Assessment-Alcohol Revised (CIWA-Ar) (Sullivan et al, 1989), 3–4 times each day for the first 5 days.”
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Bucholz, K. K., Cadoret, R., Cloninger, C. R., Dinwiddie, S. H., Hesselbrock, V. M., Nurnberger, J. I., Reich, T., Schmidt, I., & Schuckit, M. A. (1994) · Journal of Studies on Alcohol · doi:10.15288/jsa.1994.55.149 · Cited by 1,757
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Alcohol dependence syndrome: Measurement and validation.
Skinner, H. A., & Allen, B. A. (1982) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.91.3.199 · Cited by 1,061
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 759
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444 · cited 2×
“Meta-analyses of randomized clinical trials have demonstrated that 50 mg naltrexone has an overall small-to-moderate effect size in reducing drinking and relapse in alcohol dependent subjects (Anton and Swift, 2003; Garbutt et al, 1999; Mann, 2004).”
Naltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372
Gender and Age Influences on Human Brain Mu-Opioid Receptor Binding Measured by PET
Zubieta, J.-K., Dannals, R. F., & Frost, J. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.842 · Cited by 336
Self-citationmu-Opioid receptor knockout mice do not self-administer alcohol.
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · PubMed · Cited by 303
Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference
Froehlich, J. C., Harts, J., Lumeng, L., & Li, T.-K. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90174-g · Cited by 296
Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse
Gianoulakis, C. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451573 · Cited by 281
Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing
Verebey, K., Volavka, J., Mule, S. J., & Resnick, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976203315 · Cited by 270
Imaging Opiate Receptors in the Human Brain by Positron Tomography
Frost, J. J., Wagner, H. N., Dannals, R. F., Ravert, H. T., Links, J. M., Wilson, A. A., Burns, H. D., Wong, D. F., McPherson, R. W., Rosenbaum, A. E., et al. (1985) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198503000-00001 · Cited by 249
Self-citationHeinz, A., Reimold, M., Wrase, J., Hermann, D., Croissant, B., Mundle, G., Dohmen, B. M., Braus, D. H., Schumann, G., Machulla, H.-J., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.57 · Cited by 242
Oswald, L. M., & Wand, G. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.008 · Cited by 234
Self-citationWeiss, F., Mitchiner, M., Bloom, F. E., & Koob, G. F. (1990) · Psychopharmacology · doi:10.1007/bf02244123 · Cited by 228
Hubbell, C. L., Czirr, S. A., Hunter, G. A., Beaman, C. M., LeCann, N. C., & Reid, L. D. (1986) · Alcohol · doi:10.1016/0741-8329(86)90070-4 · Cited by 217
Importance of delta opioid receptors in maintaining high alcohol drinking
Froehlich, J. C., Zweifel, M., Harts, J., Lumeng, L., & Li, T. K. (1991) · Psychopharmacology · doi:10.1007/bf02244246 · Cited by 216
Ethanol consumption and reward are decreased in µ-opiate receptor knockout mice
Hall, F. S., Sora, I., & Uhl, G. R. (2001) · Psychopharmacology · doi:10.1007/s002130000622 · Cited by 213
μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward
Walters, C. L., Cleck, J. N., Kuo, Y.-C., & Blendy, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.005 · Cited by 207
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices
Levine, M. S., Li, Z., Cepeda, C., Cromwell, H. C., & Altemus, K. L. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199609)24:1<60::aid-syn7>3.0.co;2-e · Cited by 200
Self-citationPharmacotherapy of Alcohol Dependence: A Review of the Clinical Data
Mann, K. (2004) · CNS Drugs · doi:10.2165/00023210-200418080-00002 · Cited by 197
Frost, J. J., Douglass, K. H., Mayberg, H. S., Dannals, R. F., Links, J. M., Wilson, A. A., Ravert, H. T., Crozier, W. C., & Wagner, H. N. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.59 · Cited by 194
Self-citationAntagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 163
Kornet, M., Goosen, C., & Van Ree, J. M. (1991) · Psychopharmacology · doi:10.1007/bf02246038 · Cited by 161
Neuroendocrine reactivity to nicotine in smokers
Pomerleau, O. F., Fertig, J. B., Seyler, L. E., & Jaffe, J. (1983) · Psychopharmacology · doi:10.1007/bf00439275 · Cited by 159
Krishnan‐Sarin, S., Jing, S., Kurtz, D. L., Zweifel, M., Portoghese, P. S., Li, T., & Froehlich, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246191 · Cited by 148
Nylander, I., Hyytiä, P., Forsander, O., & Terenius, L. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00118.x · Cited by 147
Davenport, K. E., Houdi, A. A., & Loon, G. R. V. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90491-q · Cited by 144
Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats
Hyytiä, P. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90527-z · Cited by 142
Stromberg, M. F., Casale, M., Volpicelli, L., Volpicelli, J. R., & O’BRIEN, C. P. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00131-6 · Cited by 139
μ-Opioid Receptor Knockout Mice Do Not Self-Administer Alcohol
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39326-7 · Cited by 138
de Waele, J., Papachristou, D. N., & Gianoulakis, C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11105-1 · Cited by 129
Wang, D., Raehal, K. M., Bilsky, E. J., & Sadée, W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00362.x · Cited by 126
Rewarding effects of ethanol and cocaine in µ opioid receptor-deficient mice
Becker, A., Grecksch, G., Kraus, J., Loh, H. H., Schröeder, H., & Höllt, V. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0533-2 · Cited by 120
Current and emerging pharmacotherapies for treating tobacco dependence
Schnoll, R. A., & Lerman, C. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.429 · Cited by 119
Naltrexone Alters Subjective and Psychomotor Responses to Alcohol in Heavy Drinking Subjects
McCaul, M. E., Wand, G. S., Eissenberg, T., Rohde, C. A., & Cheskin, L. J. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00147-5 · Cited by 118
Self-citationKrishnan‐Sarin, S., Portoghese, P. S., Li, T., & Froehlich, J. C. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00080-g · Cited by 112
Wewers, M. E., Dhatt, R. K., Snively, T. A., & Tejwani, G. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01095-1 · Cited by 111
Gianoulakis, C., de Waele, J., & Kiianmaa, K. (1992) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb01399.x · Cited by 111
Effect of Mu Opioid Receptor Blockade on Alcohol Intake in Rats Bred for High Alcohol Drinking
Krishnan-Sarin, S., Wand, G. S., Li, X.-W., Portoghese, P. S., & Froehlich, J. C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00474-7 · Cited by 110
Self-citationEndogenous opioids and smoking: A review of progress and problems
Pomerleau, O. F. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00074-7 · Cited by 106
de Waele, J., Kiianmaa, K., & Gianoulakis, C. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12080-6 · Cited by 105
Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats
Marinelli, P. W., Kiianmaa, K., & Gianoulakis, C. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00517-8 · Cited by 103
Houdi, A. A., Pierzchała, K., Marson, L., Palkovits, M., & Loon, G. R. V. (1991) · Peptides · doi:10.1016/0196-9781(91)90183-p · Cited by 99
Sadzot, B., Price, J. C., Mayberg, H. S., Douglass, K. H., Dannals, R. F., Lever, J. R., Ravert, H. T., Wilson, A. A., Wagner, H. N., Feldman, M. A., et al. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.52 · Cited by 94
Self-citationNaltrexone Alteration of Acute Smoking Response in Nicotine-Dependent Subjects
King, A. C., & Meyer, P. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00258-6 · Cited by 93
Bencherif, B., Wand, G. S., McCaul, M. E., Kim, Y. K., Ilgìn, N., Dannals, R. F., & Frost, J. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.007 · Cited by 91
Self-citationHonkanen, A., Vilamo, L., Wegelius, K., Sarviharju, M., Hyytiä, P., & Korpi, E. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00118-5 · Cited by 80
Dhatt, R. K., Gudehithlu, K. P., Wemlinger, T. A., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041878.x · Cited by 80
Price, J. C., Mayberg, H. S., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sadzot, B., Rattner, Z., Kimball, A., Feldman, M. A., & Frost, J. J. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.84 · Cited by 78
Self-citationμ Opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain
Titeler, M., Lyon, R. A., Kuhar, M. J., Frost, J. F., Dannals, R. F., Leonhardt, S., Bullock, A. E., Rydelek‐Fitzgerald, L., Price, D. L., & Struble, R. G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90582-7 · Cited by 75
Self-citationThe δ 2 -opioid receptor antagonist naltriben reduces motivated responding for ethanol
June, H. L., McCane, S., Zink, R. W., Portoghese, P. S., Li, T., & Froehlich, J. C. (1999) · Psychopharmacology · doi:10.1007/s002130051145 · Cited by 74
McBride, W. J., Chernet, E., McKinzie, D. L., Lumeng, L., & Li, T. (1998) · Alcohol · doi:10.1016/s0741-8329(98)00021-4 · Cited by 72
Wand, G., McCaul, M. E., Gotjen, D., Reynolds, J., & Lee, S. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200108000-00007 · Cited by 69
Self-citationQuantification of brain μ-opioid receptors with [11C]carfentanil: reference-tissue methods
Endres, C. J., Bencherif, B., Hilton, J., Madar, I., & Frost, J. J. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00411-0 · Cited by 67
Self-citationNaltrexone blockade of nicotine effects in cigarette smokers
Brauer, L. H., Behm, F. M., Westman, E. C., Patel, P., & Rose, J. E. (1999) · Psychopharmacology · doi:10.1007/s002130050957 · Cited by 66
Current Pharmacotherapies of Alcoholism: A U.S. Perspective
Anton, R. F., & Swift, R. M. (2003) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00496.x · Cited by 65
Cowen, M. S., Rezvani, A. H., Jarrott, B., & Lawrence, A. J. (1999) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04218.x · Cited by 62
Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts
Ferrari, A., Bertolotti, M., Dell'Utri, A., Avico, U., & Sternieri, E. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00098-2 · Cited by 60
Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys
Williams, K. L., Winger, G. D., Pakarinen, E. D., & Woods, J. H. (1998) · Psychopharmacology · doi:10.1007/s002130050689 · Cited by 59
Serum 6-Beta-Naltrexol Levels Are Related to Alcohol Responses in Heavy Drinkers
McCaul, M. E., Wand, G. S., Rohde, C., & Lee, S. M. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200009000-00009 · Cited by 59
Self-citationAnatomical Localization for PET Using MR Imaging
MELTZER, C. C., Bryan, R. N., Holcomb, H. H., Kimball, A. W., Mayberg, H. S., Sadzot, B., Leal, J. P., Wagner, H. N., & Frost, J. J. (1990) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199005000-00019 · Cited by 58
Self-citationAdrenocortical Responses and Family History of Alcoholism
Wand, G. S., Mangold, D., Ali, M., & Giggey, P. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199907000-00007 · Cited by 57
Self-citationEffects of Acute and Chronic Doses of Naltrexone on Ethanol Self-Administration in Rhesus Monkeys
Boyle, A. E., Stewart, R. B., Macenski, M. J., Spiga, R., Johnson, B. A., & Meisch, R. A. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03661.x · Cited by 55
The Effects of Benzodiazepines on Human Opioid Receptor Binding and Function
Cox, R. F., & Collins, M. A. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200108000-00024 · Cited by 53
de Waele, J., & Gianoulakis, C. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90064-7 · Cited by 53
Djouma, E., & Lawrence, A. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035915 · Cited by 50
Smith, J. S., Zubieta, J., Price, J. C., Flesher, J. E., Madar, I., Lever, J. R., Kinter, C. M., Dannals, R. F., & Frost, J. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00003 · Cited by 47
Self-citationModulation of Volitional Ethanol Intake in the Rat by Central delta-Opioid Receptors
Franck, J., Lindholm, S., & Raaschou, P. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199809000-00001 · Cited by 47
Williams, K. L., & Woods, J. H. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03960.x · Cited by 46
Soini, S. L., Ovaska, T., Honkanen, A., Hyytiä, P., & Korpi, E. R. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00125-0 · Cited by 43
What Place Does Naltrexone Have in the Treatment of Alcoholism?
Rohsenow, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418090-00001 · Cited by 42
Middaugh, L. D., Kelley, B. M., Groseclose, C. H., & Cuison, E. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00184-7 · Cited by 36
In vivo binding of N1′-([11C]methyl)naltrindole to δ-opioid receptors in mouse brain
Lever, J. R., Scheffel, U., Kinter, C. M., Ravert, H. T., Dannals, R. F., Wagner, H. N., & Frost, J. J. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90448-d · Cited by 35
Self-citationDavidson, A. F., Emm, T. A., & Pieniaszek, H. J. (1996) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(96)01794-3 · Cited by 34
The metabolism of naltrexone in man.
Wall, M. E., Brine, D. R., & Perez‐Reyes, M. (1981) · PubMed · Cited by 30
Blum, K., Briggs, A. H., Wallace, J. E., Hall, C. W., & Trachtenberg, M. A. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01940430 · Cited by 30
Morphine increases intake of beer among rats
Nichols, M. L., Hubbell, C. L., Kalsher, M. J., & Reid, L. D. (1991) · Alcohol · doi:10.1016/0741-8329(91)90273-y · Cited by 29
Intracerebroventricular morphine enhances alcohol consumption by rats
Linseman, M. A., & Harding, S. E. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90423-f · Cited by 27
Selected opioids modify intake of sweetened ethanol solution among female rats
Czirr, S. A., Hubbell, C. L., Milano, W. C., Frank, J. M., & Reid, L. D. (1987) · Alcohol · doi:10.1016/0741-8329(87)90037-1 · Cited by 24
Cowen, M. S., Rezvani, A. H., Jarrott, B., & Lawrence, A. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00432-6 · Cited by 20
Nicotinic and Opioid Receptor Interactions in Nicotine Addiction
McGehee, D. S. (2006) · Molecular Interventions · doi:10.1124/mi.6.6.4 · Cited by 20
Opioids and intake of alcoholic beverages.
Reid, L. D., Sa, C., Milano, W. C., Hubbell, C. L., & Na, M. (1986) · PubMed · Cited by 7
Research works printed but not linked: 1
- Madar I, Lever JR, Kinter CM, Scheffel U, Ravert HT, Musachio JL et al (1996). Imaging of delta opioid receptors in human brain by N1′- ([11C]methyl)naltrindole and PET. Synapse 24: 19–28. · DOI · Paper page
Cited by
The changing opioid crisis: development, challenges and opportunities
Volkow, N. D., & Blanco, C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0661-4 · Cited by 522
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
Management of opioid use disorder in the USA: present status and future directions
Blanco, C., & Volkow, N. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33078-2 · Cited by 407
Alcohol and the Human Brain: A Systematic Review of Different Neuroimaging Methods
Bühler, M., & Mann, K. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01540.x · Cited by 310
Metadata
- Authors
- Weerts, E. M., Kim, Y. K., Wand, G. S., Dannals, R. F., Lee, J. S., Frost, J. J., & McCaul, M. E.
- Affiliations
- Johns Hopkins University (US)
- Seoul National University (KR)
- Corresponding author
- Weerts, Elise M
- Venue
- Neuropsychopharmacology
- Published
- 2007-05-09
- Volume
- 33
- Issue
- 3
- Pages
- 653-665
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2154071856
- Cited by
- 147
- References
- 93
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 10 · 2022: 12 · 2021: 13 · 2020: 9 · 2019: 15 · 2018: 9 · 2017: 2 · 2016: 7 · 2015: 8 · 2014: 7 · 2013: 7 · 2012: 14
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA11855, R01AA011855, R37AA012303, AA12303, AA11872, R01AA011872)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- naltrexone, mu-opioid receptor, delta opioid receptor, opioid receptor blockade, alcoholism, alcohol abstinence, [11C]carfentanil, individual differences in treatment response, brain receptor binding
- MeSH terms
- Adult, Alcoholism, Analgesics, Opioid, Data Interpretation, Statistical, Female, Fentanyl, Humans, Male, Middle Aged, Naltrexone, Narcotic Antagonists, Substance Withdrawal Syndrome, Temperance, Receptors, Opioid, mu, Receptors, Opioid, delta, Radiopharmaceuticals, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.